Mass Balance and Pharmacokinetics of [(14)C]Telavancin following Intravenous Administration to Healthy Male Volunteers

Tekijä Shaw, Jeng-Pyng, Cheong, Jonathan, Goldberg, Michael R., Kitt, Michael M.
Julkaistu 2010

Intrapulmonary Distribution of Intravenous Telavancin in Healthy Subjects and Effect of Pulmonary Surfactant on In Vitro Activities of Telavancin and Other Antibiotics

Tekijä Gotfried, Mark H., Shaw, Jeng-Pyng, Benton, Bret M., Krause, Kevin M., Goldberg, Michael R., Kitt, Michael M., Barriere, Steven L.
Julkaistu 2008

Effects of TD-5108 on Gastrointestinal Transit and Bowel Function in Health and Pharmacokinetics in Health and Constipation

Tekijä Manini, Mhd Louai, Camilleri, Michael, Goldberg, Michael, Sweetser, Seth, McKinzie, Sanna, Burton, Duane, Wong, Shekman, Kitt, Michael M., Li, Yu-Ping, Zinsmeister, Alan R.
Julkaistu 2009

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

Tekijä Stryjewski, Martin E, Lentnek, Arnold, O’Riordan, William, Pullman, John, Tambyah, Paul Anantharajah, Miró, Jose M, Fowler Jr, Vance G, Barriere, Steven L, Kitt, Michael M, Corey, G Ralph
Julkaistu 2014

Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa

Tekijä Siegal, Deborah, Lu, Genmin, Leeds, Janet M., Karbarz, Mark, Castillo, Janice, Mathur, Vandana, Hutchaleelaha, Athiwat, Sinha, Uma, Kitt, Michael, McClure, Matt, Hollenbach, Stanley J., Curnutte, John T., Conley, Pamela B., Crowther, Mark
Julkaisussa Blood Adv (2017)

Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study

Tekijä Stryjewski, Martin E., Chu, Vivian H., O'Riordan, William D., Warren, Brian L., Dunbar, Lala M., Young, David M., Vallée, Marc, Fowler, Vance G., Morganroth, Joel, Barriere, Steven L., Kitt, Michael M., Corey, G. Ralph
Julkaistu 2006

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

Tekijä Rubinstein, Ethan, Lalani, Tahaniyat, Corey, G. Ralph, Kanafani, Zeina A., Nannini, Esteban C., Rocha, Marcelo G., Rahav, Galia, Niederman, Michael S., Kollef, Marin H., Shorr, Andrew F., Lee, Patrick C., Lentnek, Arnold L., Luna, Carlos M., Fagon, Jean-Yves, Torres, Antoni, Kitt, Michael M., Genter, Fredric C., Barriere, Steven L., Friedland, H. David, Stryjewski, Martin E.
Julkaistu 2011